CETP variants with lower CETP activity have the potential to decrease Alzheimer’s disease risk, specifically in subjects carrying the APOE4 allele (Rodriguez et al., 2006; Chen et al., 2008; Oliveira and de Faria, 2011; Sundermann et al., 2016). Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.